FDA recall, , Low risk
The Blood Connection Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were prepared from whole blood that exceeded the acceptable collection volume.
Recall ended Aug 12, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The Blood Connection, Inc. recalled Red Blood Cells, Leukocytes Reduced, prepared from whole blood which exceeded the acceptable collection volume, because the product was distributed. The recall began November 4, 2025, and was added to the FDA's Enforcement Report on August 12, 2026. The product was distributed in New York.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- The Blood Connection, Inc.
- Hazard
- Quality testing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99427
- Recall number
- B-0184-2026
All recalls from The Blood Connection, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
